1. Home
  2. RZLT vs TLS Comparison

RZLT vs TLS Comparison

Compare RZLT & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • TLS
  • Stock Information
  • Founded
  • RZLT 2010
  • TLS 1969
  • Country
  • RZLT United States
  • TLS United States
  • Employees
  • RZLT N/A
  • TLS N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • RZLT Health Care
  • TLS Technology
  • Exchange
  • RZLT Nasdaq
  • TLS Nasdaq
  • Market Cap
  • RZLT 819.3M
  • TLS 496.6M
  • IPO Year
  • RZLT N/A
  • TLS 2020
  • Fundamental
  • Price
  • RZLT $9.30
  • TLS $6.71
  • Analyst Decision
  • RZLT Strong Buy
  • TLS Hold
  • Analyst Count
  • RZLT 7
  • TLS 4
  • Target Price
  • RZLT $14.86
  • TLS $5.83
  • AVG Volume (30 Days)
  • RZLT 1.5M
  • TLS 759.4K
  • Earning Date
  • RZLT 11-07-2025
  • TLS 11-10-2025
  • Dividend Yield
  • RZLT N/A
  • TLS N/A
  • EPS Growth
  • RZLT N/A
  • TLS N/A
  • EPS
  • RZLT N/A
  • TLS N/A
  • Revenue
  • RZLT N/A
  • TLS $116,739,000.00
  • Revenue This Year
  • RZLT N/A
  • TLS $47.80
  • Revenue Next Year
  • RZLT N/A
  • TLS $26.19
  • P/E Ratio
  • RZLT N/A
  • TLS N/A
  • Revenue Growth
  • RZLT N/A
  • TLS N/A
  • 52 Week Low
  • RZLT $2.22
  • TLS $1.83
  • 52 Week High
  • RZLT $10.04
  • TLS $7.72
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 54.22
  • TLS 46.17
  • Support Level
  • RZLT $8.55
  • TLS $6.38
  • Resistance Level
  • RZLT $10.03
  • TLS $6.81
  • Average True Range (ATR)
  • RZLT 0.55
  • TLS 0.32
  • MACD
  • RZLT -0.05
  • TLS -0.08
  • Stochastic Oscillator
  • RZLT 51.73
  • TLS 24.20

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: